Understanding Different Types of Hair Loss2026.03.11

Which Types Respond Better to Adipose-Derived Stem Cell Conditioned Medium, and Why

Not all hair loss is the same.

In clinical practice, hair loss may be caused by autoimmune attack, hormonal and genetic factors, temporary shedding after stress or illness, or irreversible follicular destruction due to inflammation. Because the underlying mechanism differs, the most appropriate treatment also differs. The American Academy of Dermatology classifies common hair-loss conditions separately, including alopecia areata, pattern hair loss, telogen effluvium, traction alopecia, and scarring alopecia. 

This distinction is especially important when discussing adipose-derived stem cell conditioned medium (ADSC-CM).

ADSC-CM is not a universal treatment for every type of hair loss. It tends to be more suitable when hair follicles are still present but functionally weakened, and less effective when the primary problem is severe autoimmune activity or permanent follicle destruction. 

Alopecia areata

Alopecia areata is an autoimmune disease in which the immune system attacks hair follicles. It often appears suddenly as smooth, round or oval patches of hair loss, although more extensive forms can affect the entire scalp or body. 

Diffuse hair loss

“Diffuse hair loss” is often a descriptive pattern rather than a single diagnosis. Two common causes are female pattern hair loss and telogen effluvium. Female pattern hair loss usually causes gradual thinning around the part line or crown, while telogen effluvium often follows triggers such as fever, surgery, childbirth, nutritional deficiency, psychological stress, or sudden weight loss. 

Androgenetic alopecia / female pattern hair loss

In androgenetic alopecia, the central process is follicular miniaturization. Hair follicles gradually produce thinner, shorter hairs over time. Standard treatments still center on therapies such as minoxidil and, in appropriate patients, anti-androgen-related medications. Stem cell–derived therapies are better understood as supportive or complementary options rather than established replacements for standard care. 

Scarring alopecia

In scarring alopecia, inflammation damages and eventually destroys the follicle itself. Once follicles are irreversibly lost, regenerative therapies have clear limitations. In such cases, stopping inflammation is the first priority. 

What is adipose-derived stem cell conditioned medium?

ADSC-CM does not mean injecting living stem cells themselves.

Instead, it refers to the solution containing growth factors, cytokines, and signaling molecules released by adipose-derived stem cells during culture. Reviews describe factors such as VEGF, HGF, IGF-1, PDGF, and bFGF as possible contributors to its biologic effects. 

In simple terms, ADSC-CM should not be described as a “magic liquid that grows hair.”

Rather, it is better understood as a treatment concept that may help improve the hair follicle environment, support the hair cycle, improve microcirculation, and reduce inflammatory stress around follicles. 

Which types of hair loss respond better?

More promising: androgenetic alopecia and female pattern hair loss

At present, the most supportive clinical data for ADSC-CM are in androgenetic alopecia and female pattern hair loss. Small studies and reviews have reported improvements in hair density and thickness, including a randomized double-blind controlled study showing benefit from adipose-derived stem cell extract in patients with androgenetic alopecia. However, protocols remain heterogeneous, and long-term standardization is still lacking. 

So medically, ADSC-CM is best described as a promising adjunctive therapy, not a fully established replacement for standard treatment. 

Possibly helpful in selected telogen effluvium

There are also early reports suggesting potential benefit in telogen effluvium. However, telogen effluvium always requires careful evaluation of the trigger first. Iron deficiency, thyroid disease, childbirth, medications, nutritional problems, and systemic stress must be addressed before focusing on regenerative support. 

Which types are less suitable as stand-alone targets?

Alopecia areata

Because alopecia areata is primarily an autoimmune disorder, ADSC-CM is not currently considered a strong stand-alone treatment. Theoretical anti-inflammatory and immunomodulatory effects may be helpful in some settings, but the evidence is much weaker than for androgenetic alopecia. Standard medical treatment remains the priority, depending on disease severity. 

Scarring alopecia

Scarring alopecia is even less favorable, because the follicle may already be permanently destroyed. In these cases, regenerative support alone is unlikely to be enough. 

Medical mechanisms of action

Current literature suggests several possible mechanisms:

ADSC-CM may help shift follicles from the resting phase toward the growth phase, support dermal papilla cell activity, enhance microvascular support around follicles, and reduce local inflammatory stress. These are the main reasons it appears more suitable for conditions in which follicles still exist but are weakened, such as androgenetic alopecia or selected telogen effluvium. 

Conclusion

The most suitable targets for adipose-derived stem cell conditioned medium appear to be androgenetic alopecia and female pattern hair loss, and in some cases selected telogen effluvium.

For alopecia areata, it should be viewed more cautiously and mainly as a possible adjunct, while for scarring alopecia, the indication is much more limited. 

The key point is simple:

the most important step in hair-loss treatment is not deciding what to inject first, but correctly identifying what type of hair loss the patient actually has.